Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study.
Nozza S, Malagoli A, Maia L, Calcagno A, Focà E, De Socio G, Piconi S, Orofino G, Cattelan AM, Celesia BM, Gervasi E, Guaraldi G; GEPPO Study Group. Nozza S, et al. Among authors: gervasi e. J Antimicrob Chemother. 2017 Oct 1;72(10):2879-2886. doi: 10.1093/jac/dkx169. J Antimicrob Chemother. 2017. PMID: 28605493 Free article.
Orlistat: weight lost at cost of HIV rebound.
Gervasoni C, Cattaneo D, Di Cristo V, Castoldi S, Gervasi E, Clementi E, Riva A. Gervasoni C, et al. Among authors: gervasi e. J Antimicrob Chemother. 2016 Jun;71(6):1739-41. doi: 10.1093/jac/dkw033. Epub 2016 Mar 5. J Antimicrob Chemother. 2016. PMID: 26945709 No abstract available.
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study.
Nozza S, Malagoli A, Maia L, Calcagno A, Focà E, De Socio G, Piconi S, Orofino G, Cattelan AM, Celesia BM, Gervasi E, Guaraldi G; GEPPO Study Group. Nozza S, et al. Among authors: gervasi e. J Antimicrob Chemother. 2017 Oct 1;72(10):2961. doi: 10.1093/jac/dkx282. J Antimicrob Chemother. 2017. PMID: 29091220 No abstract available.
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae.
Pérez-Nadales E, Fernández-Ruiz M, Natera AM, Gutiérrez-Gutiérrez B, Mularoni A, Russelli G, Pierrotti LC, Pinheiro Freire M, Falcone M, Tiseo G, Tumbarello M, Raffaelli F, Abdala E, Bodro M, Gervasi E, Fariñas MC, Seminari EM, Castón JJ, Marín-Sanz JA, Gálvez-Soto V, Rana MM, Loeches B, Martín-Dávila P, Pascual Á, Rodríguez-Baño J, Aguado JM, Martínez-Martínez L, Torre-Cisneros J; REIPI/INCREMENT-SOT Study Group. Pérez-Nadales E, et al. Among authors: gervasi e. Am J Transplant. 2023 Jul;23(7):1022-1034. doi: 10.1016/j.ajt.2023.03.011. Epub 2023 Apr 5. Am J Transplant. 2023. PMID: 37028515 Free article.
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.
Pinto C, Zucali PA, Pagano M, Grosso F, Pasello G, Garassino MC, Tiseo M, Soto Parra H, Grossi F, Cappuzzo F, de Marinis F, Pedrazzoli P, Bonomi M, Gianoncelli L, Perrino M, Santoro A, Zanelli F, Bonelli C, Maconi A, Frega S, Gervasi E, Boni L, Ceresoli GL. Pinto C, et al. Among authors: gervasi e. Lancet Oncol. 2021 Oct;22(10):1438-1447. doi: 10.1016/S1470-2045(21)00404-6. Epub 2021 Sep 6. Lancet Oncol. 2021. PMID: 34499874 Clinical Trial.
ROS1 rearrangements are uncommon in biliary tract cancers.
Mazzoni F, Petreni P, Vasile E, Panebianco M, Casadei-Gardini A, Negri F, Lunghi A, Pillozzi S, Vivaldi C, Gervasi E, Frassineti GL, Messerini L, Jocollé G, Bisagni A, Antonuzzo L, Rossi G. Mazzoni F, et al. Among authors: gervasi e. Oncol Lett. 2020 Dec;20(6):316. doi: 10.3892/ol.2020.12179. Epub 2020 Oct 1. Oncol Lett. 2020. PMID: 33133252 Free PMC article.
26 results